These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 32872164)

  • 1. Fatty Acid Synthase: An Emerging Target in Cancer.
    Fhu CW; Ali A
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathways: Fatty Acid Synthase.
    Jones SF; Infante JR
    Clin Cancer Res; 2015 Dec; 21(24):5434-8. PubMed ID: 26519059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Development of Fatty Acid Synthase Inhibitors as Anticancer Agents.
    Singh S; Karthikeyan C; Moorthy NSHN
    Mini Rev Med Chem; 2020; 20(18):1820-1837. PubMed ID: 32781957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of lipogenic enzymes as a potential therapy against cancer.
    Montesdeoca N; López M; Ariza X; Herrero L; Makowski K
    FASEB J; 2020 Sep; 34(9):11355-11381. PubMed ID: 32761847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase as a potential therapeutic target in cancer.
    Flavin R; Peluso S; Nguyen PL; Loda M
    Future Oncol; 2010 Apr; 6(4):551-62. PubMed ID: 20373869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase inhibitors: new directions for oncology.
    Kridel SJ; Lowther WT; Pemble CW
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1817-29. PubMed ID: 17970640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
    Lupu R; Menendez JA
    Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells.
    Benjamin DI; Li DS; Lowe W; Heuer T; Kemble G; Nomura DK
    ACS Chem Biol; 2015 Jul; 10(7):1616-23. PubMed ID: 25871544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors.
    Vandhana S; Coral K; Jayanthi U; Deepa PR; Krishnakumar S
    Biochim Biophys Acta; 2013 Sep; 1831(9):1458-66. PubMed ID: 23816424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fatty acid synthase: a new anti-tumor target].
    Puig T; Porta R; Colomer R
    Med Clin (Barc); 2009 Mar; 132(9):359-63. PubMed ID: 19268984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
    Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
    Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
    Lupu R; Menendez JA
    Endocrinology; 2006 Sep; 147(9):4056-66. PubMed ID: 16809439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
    Goswami S; Sharma-Walia N
    Oncotarget; 2016 Sep; 7(37):58953-58974. PubMed ID: 27270654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments.
    Wu X; Qin L; Fako V; Zhang JT
    Adv Biol Regul; 2014 Jan; 54():214-21. PubMed ID: 24080588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Inhibitor of Fatty Acid Synthase Thioesterase Domain with Improved Cytotoxicity against Breast Cancer Cells and Stability in Plasma.
    Lupien LE; Dunkley EM; Maloy MJ; Lehner IB; Foisey MG; Ouellette ME; Lewis LD; Pooler DB; Kinlaw WB; Baures PW
    J Pharmacol Exp Ther; 2019 Oct; 371(1):171-185. PubMed ID: 31300609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel small-molecule fatty acid synthase inhibitor with antitumor activity by cell cycle arrest and cell division inhibition.
    Qu H; Shan K; Tang C; Cui G; Fu G; Qi Y; Cui J; Li J; Wang R; Feng N; Chen YQ
    Eur J Med Chem; 2021 Jul; 219():113407. PubMed ID: 33901805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.
    Menendez JA; Lupu R
    Nat Rev Cancer; 2007 Oct; 7(10):763-77. PubMed ID: 17882277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors.
    Angeles TS; Hudkins RL
    Expert Opin Drug Discov; 2016 Dec; 11(12):1187-1199. PubMed ID: 27701891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.
    Bauerschlag DO; Maass N; Leonhardt P; Verburg FA; Pecks U; Zeppernick F; Morgenroth A; Mottaghy FM; Tolba R; Meinhold-Heerlein I; Bräutigam K
    J Transl Med; 2015 May; 13():146. PubMed ID: 25947066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short communication: Effect of inhibition of fatty acid synthase on triglyceride accumulation and effect on lipid metabolism genes in goat mammary epithelial cells.
    Zhu JJ; Luo J; Sun YT; Shi HB; Li J; Wu M; Yu K; Haile AB; Loor JJ
    J Dairy Sci; 2015 May; 98(5):3485-91. PubMed ID: 25726120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.